DE550833C - Process for transferring bacterial preparations, bacterial extracts, toxins, sera and the like Like. In durable products that easily penetrate the skin and mucous membranes - Google Patents

Process for transferring bacterial preparations, bacterial extracts, toxins, sera and the like Like. In durable products that easily penetrate the skin and mucous membranes

Info

Publication number
DE550833C
DE550833C DEW67544D DEW0067544D DE550833C DE 550833 C DE550833 C DE 550833C DE W67544 D DEW67544 D DE W67544D DE W0067544 D DEW0067544 D DE W0067544D DE 550833 C DE550833 C DE 550833C
Authority
DE
Germany
Prior art keywords
bacterial
skin
mucous membranes
sera
toxins
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DEW67544D
Other languages
German (de)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CARL NEUBERG DR
ALICE VON WASSERMANN GEB VON T
FRANZ RUDOLF VON WASSERMANN
ROBERT SIEGFRIED VON WASSERMAN
Original Assignee
CARL NEUBERG DR
ALICE VON WASSERMANN GEB VON T
FRANZ RUDOLF VON WASSERMANN
ROBERT SIEGFRIED VON WASSERMAN
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CARL NEUBERG DR, ALICE VON WASSERMANN GEB VON T, FRANZ RUDOLF VON WASSERMANN, ROBERT SIEGFRIED VON WASSERMAN filed Critical CARL NEUBERG DR
Priority to DEW67544D priority Critical patent/DE550833C/en
Application granted granted Critical
Publication of DE550833C publication Critical patent/DE550833C/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Description

Verfahren zur Überführung von Bakterienpräparaten, Bakterienextrakten, Toxinen, Sera u. dgL in haltbare, die Haut und die Schleimhäute leicht durchdringende Produkte Gegenstand der vorliegenden Erfindung ist ein Verfahren zur Überführung von zu Heil-und Immunisierungsnvecken dienenden Bakterienpräparaten, Bakterienextrakten, Toxinen, Sera u. dgl. in haltbare, die Haut und die Schleimhäute leicht durchdringende Produkte. Die genannten Ausgangsstoffe, die von der Haut und den Schleimhäuten entweder überhaupt nicht oder nur in geringen Mengen durchgelassen werden, werden gemäß vorliegender Erfindung in eine Form übergeführt, in der sie nunmehr die Außenhaut und die Schleimhäute leicht und in reichlicher Menge zu durchdringen vermögen.Process for the transfer of bacterial preparations, bacterial extracts, Toxins, sera and the like in durable, easily penetrating the skin and mucous membranes Products The present invention relates to a process for transferring of bacterial preparations used for healing and immunization, bacterial extracts, Toxins, sera and the like in durable, easily penetrating skin and mucous membranes Products. The starting materials mentioned come from the skin and the mucous membranes either are not allowed to pass through at all or only in small amounts, are in accordance with the present Invention converted into a form in which it now covers the outer skin and the mucous membranes able to penetrate easily and in abundance.

Das Verfahren besteht im weseritlichen darin, daß man die Bakterienpräparate, Sera usw. in getrocknetem Zustande mit geeigneten Mengen benzo:esauren Natriums innig vermengt, worauf dieses Gemenge in an sich bekannter Weise in geeignete verabreichbare Form gebracht werden kann, z. B. in die Form von Pastillen, - Tabletten, Pillen, Kapseln, Salben, Schiittelmixturen usw. Die erhaltenen Produkte zeichnen sich zunächst durch eine fast unbegrenzte Haltbarkeit aus, sie besitzen ferner aber die wertvolle physikalische Eigenschaft, die Schleimhäute des Magen-Darm-Kanals und auch die Außenhaut zu durchdringen, so daß also eine Einführung der betreffenden Ausgangsstoffe in die Blutbahn und in die Körpersäfte nicht erforderlich ist, sondern die Darreichung per os erfolgen kann. Beispiele i. Der Bakterienrasen einer oder mehrerer Agarkulturen von Mäusetyphusb,azillen wurde abgeschwemmt, abgetötet und getrocknet, worauf man das trockne Pulver mit der zehnfachen Menge seines Gewichtes oder mit noch größeren Mengen von trockenem benzoesaurem Natrium innig vermischt. Die erhaltenen Produkte sind längere Zeit ohne Zersetzung haltbar. Das Gemenge wurde Mäusen in den Magen einverleibt. Nach sechsmaliger Wiederholung wurden die Mäuse sowie die Kontrolltiere mit lebenden Mäusetyphusbazillen gefüttert. Alle vorbehandelten Mäuse blieben am Leben, die nicht vorbehandelten Tiere Erlagen sämtlich der Infektion. Die Verfütterung des Präparates hat also Immunität ausgelöst.The process consists essentially in the fact that the bacterial preparations, Sera, etc. in the dried state with suitable amounts of sodium benzoate intimately mixed, whereupon this mixture in a manner known per se in suitable administrable Can be brought into shape, e.g. B. in the form of lozenges, tablets, pills, Capsules, ointments, Schiittelmixturen etc. The products obtained stand out first characterized by an almost unlimited shelf life, but they also have the valuable physical property, the mucous membranes of the gastrointestinal tract and also the outer skin to penetrate, so that an introduction of the starting materials in question in the bloodstream and the body fluids are not required, but the administration can be done per os. Examples i. The bacterial lawn of one or more agar cultures of mouse typhusb, acilli was washed away, killed and dried, whereupon one the dry powder ten times its weight or even greater Quantities of dry sodium benzoate intimately mixed. The products received can be kept for a long time without decomposition. The mixture was put into the stomach of mice incorporated. After repeating six times, the mice became the control animals fed with live mouse typhus bacilli. All pretreated mice remained on Life, the animals that had not been pretreated all succumbed to the infection. The feeding of the preparation has triggered immunity.

a. Die gleiche orale Behandlung mit entsprechender Veränderung der Mengenverhältnisse wurde mittels abgetöteter DysenteTie-und Typhusbazillen an Kaninchen vorgenommen. Es ergab sich, daß die mit dem aus Dysenterieerregern und bänzoesaurem Natrium hergestellten Präparate gefütterten Kaninchen immun-waren. Bei den Typhuskaninchen zeigte sich, daß sie durch Verfütterung des aus abgetöteten Typhusbazillen und benzoesaurem Natrium hergestellten Präparates eine starke Anhäufung von spezifischen Schutzstoffen im Serum erhielten. Es wurde also damit eine Wirkung erreicht, die bisher nur durch Injektion, nie aber vom Magen-Darm-Kanal aus erreicht werden konnte.a. The same oral treatment with a corresponding change in the Quantities were determined by means of killed DysenteTie and typhus bacilli in rabbits performed. It turned out that those with the from dysentery pathogens and preparations made from sodium benzenoate were immune to fed rabbits. The typhus rabbits were found to have been killed by feeding the rabbits from Typhoid bacilli and sodium benzoate produced a large accumulation of specific protective substances in the serum. So it became an effect which was previously only achieved by injection, but never from the gastrointestinal tract could be.

Durch das neue Verfahren werden also Stoffe, die bisher in bestimmten Medien unlöslich waren, nicht allein darin leicht löslich gemacht, sondern die empfindlichen Heil-und Immunstoffe werden unerwarteterweise durch das Vermischen mit benzoesaurem Natrium in eine so beständige Form übergeführt, daß sie lange Lagerung ohne Zersetzung vertragen. Dabei wird auch die Heil-und Immunisierwirkung in keiner Weise geschwächt, sondern im Gegenteil. dadurch erhöht, daß die neuen Präparate infolge des Gehaltes an Benzoat die Haut- und Schleimhäute zu durchdringen vermögen. Es ist zwar bekannt, Bakteriensuspensionen durch Zusatz von benzoesauren Salzen aufzuhellen. Neu demgegenüber ist aber die Feststellung, daß man Präparate oder Extrakte von Bakterien, ferner Toxine, S,eTa u. dgl. Heilstoffe in trockenem Zustande durch Vermischen mit Natriumbenzoat in eine lagerbeständige Form überführen kann, in der sie außerdem die neue physikalische Eigenschaft erhalten, die Zellen der Haut und der Schleimhäute zu durchdringen.With the new process, substances that were previously in certain Media were insoluble, not only made easily soluble in them, but the sensitive ones Medicinal and immune substances are unexpectedly obtained by mixing with benzoic acid Sodium converted into such a stable form that it can be stored for a long time without decomposition tolerate. The healing and immunizing effect is not weakened in any way, but on the contrary. increased by the fact that the new preparations as a result of the content of benzoate are able to penetrate the skin and mucous membranes. It is well known Lighten bacterial suspensions by adding benzoic acid salts. New in comparison but it is also the statement that preparations or extracts of bacteria are also available Toxins, S, eTa and similar medicinal substances in the dry state by mixing with sodium benzoate can be converted into a storage-stable form in which it also contains the new physical Preserved the ability to penetrate the cells of the skin and mucous membranes.

Claims (1)

PATLNN, T.1N 51'I,UC11 Verfahren zur Überführung von Bakterienpräparaten, Bakterienextrakten, Toxinen, Sera u. dgl. in haltbare, die Haut und die Schleimhäute leicht durchdringende Produkte, dadurch gekennzeichnet, daß man die Bakterienpräparate, Sakterienextrakte usw. in getrocknetem Zustande mit geeigneten Mengen von beenzoesaurem Natrium innig vermengt, worauf das Gemisch in an sich bekannter Weise in verabreichbare Form gebracht werden kann.PATLNN, T.1N 51'I, UC11 Procedure for transferring bacterial preparations, Bacterial extracts, toxins, sera and the like in durable, the skin and the mucous membranes easily penetrating products, characterized in that the bacterial preparations, Dried bacterial extracts, etc. with appropriate amounts of beenzoic acid Sodium intimately mixed, whereupon the mixture in a known manner in administrable Form can be brought.
DEW67544D 1924-11-09 1924-11-09 Process for transferring bacterial preparations, bacterial extracts, toxins, sera and the like Like. In durable products that easily penetrate the skin and mucous membranes Expired DE550833C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DEW67544D DE550833C (en) 1924-11-09 1924-11-09 Process for transferring bacterial preparations, bacterial extracts, toxins, sera and the like Like. In durable products that easily penetrate the skin and mucous membranes

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DEW67544D DE550833C (en) 1924-11-09 1924-11-09 Process for transferring bacterial preparations, bacterial extracts, toxins, sera and the like Like. In durable products that easily penetrate the skin and mucous membranes

Publications (1)

Publication Number Publication Date
DE550833C true DE550833C (en) 1932-05-20

Family

ID=7607899

Family Applications (1)

Application Number Title Priority Date Filing Date
DEW67544D Expired DE550833C (en) 1924-11-09 1924-11-09 Process for transferring bacterial preparations, bacterial extracts, toxins, sera and the like Like. In durable products that easily penetrate the skin and mucous membranes

Country Status (1)

Country Link
DE (1) DE550833C (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4153683A (en) * 1976-03-15 1979-05-08 Biotest-Serum-Institut Gmbh Galenic immune-globulin preparation
US4335099A (en) * 1975-05-29 1982-06-15 The Green Cross Corporation Employment of enteric coated IgA for hypoproteinemia in intestinal infectious diseases

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4335099A (en) * 1975-05-29 1982-06-15 The Green Cross Corporation Employment of enteric coated IgA for hypoproteinemia in intestinal infectious diseases
US4153683A (en) * 1976-03-15 1979-05-08 Biotest-Serum-Institut Gmbh Galenic immune-globulin preparation

Similar Documents

Publication Publication Date Title
DE2833013A1 (en) NEW ALUMINUM-SULFUR COMPOUND, METHOD OF MANUFACTURING IT, AND MEANS OF CONTAINING THIS COMPOUND
DD144719A5 (en) METHOD FOR OBTAINING A NATURAL POLAR FRACTION WITH ANTIPSORIATIC EFFECTIVENESS
DE2140719A1 (en) Medicines based on a pyrazolone
DE550833C (en) Process for transferring bacterial preparations, bacterial extracts, toxins, sera and the like Like. In durable products that easily penetrate the skin and mucous membranes
DE2103387A1 (en) Compns of glucosamine hydrochloride and anti-rheumatic - agent - for treatment of arthrosis and arthritis,with reduced toxicit
DE2721014A1 (en) MEDICINAL PRODUCT CONTAINING ECHINACEA AND LACTIC ACID DERIVATIVES
DE1792256C3 (en) Orally administered, polyvalent vaccines against local intestinal infections
DE2929009A1 (en) PREPARATION AGAINST BACTERIAL DISEASES
DE1192635B (en) Process for the production of bismuth pectinate
DE2334376A1 (en) IMMUNOLOGICAL PRODUCT, ITS USE AND METHOD FOR ITS MANUFACTURING
DE3000521A1 (en) SUBSTANCE WITH INTERFERON INDUCING ACTIVITY AND METHOD FOR THEIR PRODUCTION
DE1043587B (en) Process for making an appetite suppressant
DE1717100A1 (en) Process for the production of anti-carcinomatous preparations of haemolytic streptococci
DE2104851A1 (en)
DE1910716A1 (en) Antimicrobial drug and its uses
DE2235348A1 (en) MEDICINAL PRODUCTS FOR TREATMENT AND USE OF GONORRHOUS
US3071508A (en) Compositions for oral administration in unit dosage form for prophylaxis and treatment of poison ivy and poison sumac dermatitis
AT330953B (en) METHOD OF MANUFACTURING A PHARMACEUTICAL PREPARATION FOR IMPROVING CELL RESPIRATION
DE1950403A1 (en) New pharmaceutical compositions based on formocaseins
DE2156806C2 (en) Arginine acetylsalicylates, processes for their production and pharmaceutical preparations containing them
DE2015877A1 (en) drug
DE2317138C3 (en) Cosmetic hair tonic
DE69730596T2 (en) COMBINED THE ALLOPATHIC AND ITS APPROPRIATE HOMEOPHATIC SUBSTANCES
DE2753466A1 (en) Prunus spp. unsaponifiable fraction extract - with antiinflammatory, hypouricaemic and thrombocyte aggregation inhibiting activity
DE1492179A1 (en) Process for the production of percutaneously effective preparations of vaccines